BioWorld Science

July 25, 2022

View Archived Issues

High GPR87 expression is associated with poor prognosis in lung adenocarcinoma

Newsoara Biopharma presents new PLK1 inhibitors

National Institute of Pharmaceutical R&D discovers compounds for diseases caused by toxic aldehydes

CACMS identifies febrifugine as a potential treatment for visceral leishmaniasis

Vicebio launches to advance vaccines against respiratory viral infections

Sanofi to advance NK cell engager from Innate Pharma collaboration into IND-enabling studies

Ketamine-inspired compound shows efficacy in rat model of renal I/R injury

Thanks for the good memories: neurotensin codes for positive valence in associative learning

Androgen receptor-targeting PROTACs synthesized at Arvinas Operations

Ultra-long-acting dolutegravir prodrug formulation may enhance treatment compliance

Today's news in brief

BioWorld

BioWorld briefs for April 17, 2026.

MMP inhibitors divulged in Accure Therapeutics patent

BioWorld Science

Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...

News in brief

BioWorld Asia

BioWorld Asia briefs for April 14, 2026

Elderly woman holding illustration of brain with missing puzzle piece

Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’

BioWorld

The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...

Selective CBL-B inhibitor with improved safety profile disclosed

BioWorld Science

CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...